Abstract:
:The randomized clinical trial, LU19, conducted by the Medical Research Council Lung Cancer Working Party, was designed to compare ACE (doxorubicin, cyclophosphamide and etoposide) chemotherapy plus G-CSF (granulocyte colony-stimulating factor) at 2-week intervals versus ACE chemotherapy alone at standard 3-week intervals in patients with small-cell lung cancer. This trial investigated whether more intensive administration of ACE would improve overall survival and affect the quality of life of patients. The report on overall survival and other outcome measures will be published in the Journal of Clinical Oncology. In this paper we focus on methods of analysing aspects of data reflecting quality of life. Twelve symptoms of lung cancer and its treatment - cough, haemoptysis, pain, nausea, vomiting, hoarse voice, sore mouth, rash, lethargy, lack of appetite, alopecia, and dysphagia - were scheduled to be assessed on seven occasions for the ACE arm and on eight occasions for the ACE+G-CSF arm by clinicians during the first 18 weeks of the treatment period. However, in practice the number of assessment forms completed per patient ranged from 1 to 9, and assessment time-points were very different from those planned. These 'messy' longitudinal data are explored by both a summary measure approach, in which experience of a symptom is summarized by a single value, and an extensive model-based statistical approach, which explicitly takes into account correlation within repeated measures. These analyses provide a clear picture of symptom comparisons between the two treatments. The application of various methods offers not only an approach to assessing the robustness of the results but also a basis for investigating reasons for inconsistency of results across methods. We conclude that except lethargy, which is worse in the ACE+G-CSF arm, all symptoms are similar across the two arms during the treatment period.
journal_name
Stat Medjournal_title
Statistics in medicineauthors
Qian W,Parmar MK,Sambrook RJ,Fayers PM,Girling DJ,Stephens RJdoi
10.1002/1097-0258(20001015)19:19<2657::aid-sim557>subject
Has Abstractpub_date
2000-10-15 00:00:00pages
2657-74issue
19eissn
0277-6715issn
1097-0258pii
10.1002/1097-0258(20001015)19:19<2657::AID-SIM557>journal_volume
19pub_type
临床试验,杂志文章abstract::In many chronic disease processes subjects are at risk of two or more types of events. We describe a bivariate mixed Poisson model in which a copula function is used to model the association between two gamma distributed random effects. The resulting model is a bivariate negative binomial process in which each type of...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.3830
更新日期:2010-03-15 00:00:00
abstract::A method is proposed to infer the randomized treatment effect on survival after an adjustment for a post-randomization variable. The post-randomization variable is made independent of the treatment assignment and is considered a surrogate for baseline prognostic factors. The relationship between the post-randomization...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.968
更新日期:2001-11-30 00:00:00
abstract::In biomedical studies and clinical trials, repeated measures are often subject to some upper and/or lower limits of detection. Hence, the responses are either left or right censored. A complication arises when more than one series of responses is repeatedly collected on each subject at irregular intervals over a perio...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.8017
更新日期:2019-03-15 00:00:00
abstract::Prevalent sampling is frequently a convenient and economical sampling technique for the collection of time-to-event data and thus is commonly used in studies of the natural history of a disease. However, it is biased by design because it tends to recruit individuals with longer survival times. This paper considers est...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.7184
更新日期:2017-04-15 00:00:00
abstract::Bioequivalence or interaction trials are commonly studied in crossover design and can be analysed by nonlinear mixed effects models as an alternative to noncompartmental approach. We propose an extension of the population Fisher information matrix in nonlinear mixed effects models to design crossover pharmacokinetic t...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.4390
更新日期:2012-05-20 00:00:00
abstract::In this paper statistical methods are proposed to estimate the distribution of a CD4 T-cell number at the time of a clinical AIDS endpoint from serial measurements of CD4 T-cell values in a cohort study. The statistical formulation of the problem is that of survival analysis with interval censored data, but in which t...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.4780131915
更新日期:1994-10-15 00:00:00
abstract::The introduction of potent antiretroviral therapies for treatment of HIV infection typically results in a dramatic reduction in plasma HIV RNA concentration, often to levels undetectable by current measurement practices. However, although a high proportion of patients achieve 'undetectability', many then experience a ...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.1325
更新日期:2003-02-15 00:00:00
abstract::We study the competing risks model and show that the cause j cumulative incidence function integrated from 0 to τ has a natural interpretation as the expected number of life years lost due to cause j before time τ. This is analogous to the τ-restricted mean lifetime, which is the survival function integrated from 0 to...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.5903
更新日期:2013-12-30 00:00:00
abstract::Wittes and Brittain recommended using an 'internal pilot study' to adjust sample size. The approach involves five steps in testing a general linear hypothesis for a general linear univariate model, with Gaussian errors. First, specify the design, hypothesis, desired test size, power, a smallest 'clinically meaningful'...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/(sici)1097-0258(19990530)18:10<1199::aid-s
更新日期:1999-05-30 00:00:00
abstract::A method is presented which allows us to adapt the sample size as well as the number and time points of interim analyses to the treatment difference observed at an interim look during the course of a clinical trial with censored survival time as the endpoint. The method allows the inclusion of data inspections during ...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.1136
更新日期:2001-12-30 00:00:00
abstract::Researchers in clinical science and bioinformatics frequently aim to learn which of a set of candidate biomarkers is important in determining a given outcome, and to rank the contributions of the candidates accordingly. This article introduces a new approach to research questions of this type, based on targeted maximu...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.3414
更新日期:2009-01-15 00:00:00
abstract::Graphical methods based on the analysis of differences between log cumulative hazard functions are considered for a two-group semi-proportional hazard model which allows for interaction between treatments and covariates. Confidence procedures and test statistics that can be used to test for interaction and for main ef...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.4780111105
更新日期:1992-08-01 00:00:00
abstract::The change in c-statistic is frequently used to summarize the change in predictive accuracy when a novel risk factor is added to an existing logistic regression model. We explored the relationship between the absolute change in the c-statistic, Brier score, generalized R(2) , and the discrimination slope when a risk f...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.5598
更新日期:2013-02-20 00:00:00
abstract::Most phase I dose-finding methods in oncology aim to find the maximum-tolerated dose from a set of prespecified doses. However, in practice, because of a lack of understanding of the true dose-toxicity relationship, it is likely that none of these prespecified doses are equal or reasonably close to the true maximum-to...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.6933
更新日期:2016-09-10 00:00:00
abstract::A considerable number of the clinical reports which are presented to the Dutch Board for the Evaluation of Drugs, have deficiencies and/or shortcomings. A number of these, including loose description of the target population and sampling method, methodological flaws, incorrect treatment of withdrawals, confounding of ...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.4780020209
更新日期:1983-04-01 00:00:00
abstract::We propose a two-step procedure to personalize drug dosage over time under the framework of a log-linear mixed-effect model. We model patients' heterogeneity using subject-specific random effects, which are treated as the realizations of an unspecified stochastic process. We extend the conditional quadratic inference ...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.7016
更新日期:2016-10-30 00:00:00
abstract::Optimal prevention and treatment strategies for a disease of multiple causes, such as pneumonia, must be informed by the population distribution of causes among cases, or cause-specific case fractions (CSCFs). CSCFs may further depend on additional explanatory variables. Existing methodological literature in disease e...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.8804
更新日期:2021-02-20 00:00:00
abstract::Much has been published on various aspects of data analysis and reporting from clinical trials within the biopharmaceutical environment. This ranges from regulatory guidelines on the format and content of registration dossiers to recommendations on data presentation and the statistical methodologies that are appropria...
journal_title:Statistics in medicine
pub_type: 杂志文章,评审
doi:10.1002/(sici)1097-0258(19980815/30)17:15/16<1829:
更新日期:1998-08-15 00:00:00
abstract::This article concerns construction of a confidence surface for tangential slopes of the dose-response surface of a combination therapy to identify where response increases as a function of drug dosage. This approach extends to the assessment of the effectiveness of the combination therapy. ...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.4780110513
更新日期:1992-03-01 00:00:00
abstract::Systematic reviews often provide recommendations for further research. When meta-analyses are inconclusive, such recommendations typically argue for further studies to be conducted. However, the nature and amount of future research should depend on the nature and amount of the existing research. We propose a method ba...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.5524
更新日期:2013-01-15 00:00:00
abstract::We consider evaluation and comparison of the diagnostic accuracy of biomarkers with continuous test outcomes, possibly correlated due to repeated measurements. We develop nonparametric group sequential testing procedures to evaluate and compare the area of biomarkers under their receiver operating characteristic curve...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.3203
更新日期:2008-05-10 00:00:00
abstract::A measure of similarity for response curves is presented and its potential use is discussed. The distribution of a suitable test statistic for testing the independence of the course of two curves is derived. The method proposed is compared with other proposals in the literature for the analysis of paired response curv...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.4780081112
更新日期:1989-11-01 00:00:00
abstract::Models for infant growth have usually been based on parametric forms, commonly an exponential or similar model, which have been shown to fit poorly especially during the first year of life. An alternative approach is to use a non-parametric model, based on a shape invariant model (SIM), where a single function is tran...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.2718
更新日期:2007-05-30 00:00:00
abstract::In a cluster randomized cross-over trial, all participating clusters receive both intervention and control treatments consecutively, in separate time periods. Patients recruited by each cluster within the same time period receive the same intervention, and randomization determines order of treatment within a cluster. ...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.2537
更新日期:2007-01-30 00:00:00
abstract::For genome-wide association studies, we propose a new method for identifying significant biological pathways. In this approach, we aggregate data across single-nucleotide polymorphisms to obtain summary measures at the gene level. We then use a hierarchical Bayesian model, which takes the gene-level summary measures a...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.4477
更新日期:2012-05-10 00:00:00
abstract::The serial dilution assay (for example, an in vitro antimicrobic susceptibility test or a serum antibody titer assay) is an important technique in biomedical research. The structure of the experiment forces grouping of the threshold concentrations into intervals. Statistical methods to analyse threshold concentrations...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.4780070410
更新日期:1988-04-01 00:00:00
abstract::In this study, 401 cases of childhood cancer in four California counties in 1980-1988 were analysed with the innovative methodology of density equalizing map projections. The data were originally collected and analysed by the California State Department of Health Services (DHS). In addition to the new analytic techniq...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.686
更新日期:2001-05-15 00:00:00
abstract::Biological drug products are therapeutic moieties manufactured by a living system or organisms. These are important life-saving drug products for patients with unmet medical needs. Because of expensive cost, only a few patients have access to life-saving biological products. Most of the early biological products will ...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.5565
更新日期:2013-02-10 00:00:00
abstract::Among many other uses, positron emission tomography (PET) can be used in studies to estimate the density of a neuroreceptor at each location throughout the brain by measuring the concentration of a radiotracer over time and modeling its kinetics. There are a variety of kinetic models in common usage and these typicall...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.3510
更新日期:2009-03-15 00:00:00
abstract::Studies based on aggregated hospital outcome data have established that there is a relationship between nurse staffing and adverse events. However, this result could not be confirmed in Belgium where 96 per cent of the variability of nurse staffing levels over nursing units (belonging to different hospitals) is explai...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.3756
更新日期:2010-03-30 00:00:00